Gastric lavage with paraffin oil for aluminum phosphide poisoning
Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial
This study tests if using paraffin oil for stomach washing can help people who have been poisoned by aluminum phosphide recover better than using regular saline or sodium bicarbonate.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 62 (estimated) |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Trial ID | NCT04499885 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of gastric lavage using paraffin oil in patients suffering from acute aluminum phosphide poisoning. It is a randomized controlled clinical trial comparing the outcomes of paraffin oil gastric lavage against traditional saline and sodium bicarbonate lavage. The goal is to determine if paraffin oil can improve patient recovery and reduce toxicity from aluminum phosphide exposure. The trial will include symptomatic patients who meet specific inclusion criteria while excluding those with certain medical conditions or previous interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are symptomatic patients who have experienced acute aluminum phosphide poisoning.
Not a fit: Patients who may not benefit include those who are asymptomatic, have ingested other substances, or have significant pre-existing medical conditions.
Why it matters
Potential benefit: If successful, this approach could provide a more effective treatment option for patients suffering from acute aluminum phosphide poisoning.
How similar studies have performed: There is limited information on the success of similar approaches, making this study a potentially novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients with symptomatic acute aluminum phosphide poisoning Exclusion Criteria: * • Pregnant and lactating women * Asymptomatic patients with history of acute aluminum phosphide exposure. * Patients with ingestion or exposure to other substances in addition to aluminum phosphide. * Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure). * Patients with previous medical intervention (had gastric lavage in any medical center before admission). * Patients with disturbed consciousness level * Patients with post cardiac arrest cases
Where this trial is running
Tanta
- Sherief Abd-Elsalam — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: Nadia Ezzat Helal, Ass. Prof. — Forensic medicine Department- Tanta University
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.